1. Home
  2. EBF vs DCTH Comparison

EBF vs DCTH Comparison

Compare EBF & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

N/A

Current Price

$21.06

Market Cap

538.9M

ML Signal

N/A

DCTH

Delcath Systems Inc.

N/A

Current Price

$19.94

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBF
DCTH
Founded
1909
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.9M
578.4M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
EBF
DCTH
Price
$21.06
$19.94
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $24.00
AVG Volume (30 Days)
139.0K
★ 302.4K
Earning Date
12-21-2026
11-09-2026
Dividend Yield
★ 5.04%
N/A
EPS Growth
7.79
★ 107.53
EPS
★ 0.76
0.04
Revenue
N/A
N/A
Revenue This Year
$1.01
$24.61
Revenue Next Year
$0.92
$24.27
P/E Ratio
★ $27.43
$374.00
Revenue Growth
N/A
N/A
52 Week Low
$16.33
$8.12
52 Week High
$23.09
$17.42

Technical Indicators

Market Signals
Indicator
EBF
DCTH
Relative Strength Index (RSI) 34.99 78.56
Support Level $20.81 $14.14
Resistance Level $21.30 N/A
Average True Range (ATR) 0.53 0.68
MACD -0.17 0.41
Stochastic Oscillator 14.63 99.02

Price Performance

Historical Comparison
EBF
DCTH

About EBF Ennis Inc.

Ennis Inc is a trade printer company that manufactures a broad range of printed products throughout the United States. It is engaged in the business of manufacturing, designing, and selling business forms and other printed business products to distributors located in the United States. Through a network of independent distributors, its channel encompasses independent print distributors, commercial printers, direct mail, fulfillment companies, payroll and accounts payable software companies, and advertising agencies, among others. The group operates in a single reportable segment called Print and derives its operating revenues from the manufacturing of mostly custom or semi-custom printed products sold mostly to independent distributors in the United States.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: